Old Web
English
Sign In
Acemap
>
authorDetail
>
Laure Devlamynck
Laure Devlamynck
Medicine
Phases of clinical research
Multiple myeloma
Lenalidomide
Oncology
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myélome (IFM)
2021
Blood
Aurore Perrot
Valérie Lauwers-Cances
Cyrille Touzeau
Olivier Decaux
Cyrille Hulin
Magaret Macro
Anne-Marie Stoppa
Marie-Lorraine Chretien
Lionel Karlin
Clara Mariette
Caroline Jacquet
Murielle Roussel
Coralie Guillemot
Laure Devlamynck
Hervé Avet-Loiseau
Philippe Moreau
Michel Attal
Show All
Source
Cite
Save
Citations (0)
Twice Weekly Induction with Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination Followed By Extended IRD Consolidation and Lenalidomide Maintenance in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du Myelome (IFM 2014-03)
2019
Blood
Murielle Roussel
Benjamin Hebraud
Cyrille Hulin
Xavier Leleu
Thierry Facon
Eileen M Boyle
Cyrille Touzeau
Brigitte Pegourie
Aurore Perrot
Anne-Marie Stoppa
Jean-Pierre Marolleau
Philippe Moreau
Hervé Avet-Loiseau
Laure Devlamynck
Valérie Lauwers-Cances
Michel Attal
Show All
Source
Cite
Save
Citations (4)
Analysis of a binary composite endpoint with missing data in components
2007
Statistics in Medicine
Hui Quan
Daowen Zhang
Ji Zhang
Laure Devlamynck
Show All
Source
Cite
Save
Citations (13)
1